Biallelic PI4KA variants cause neurological, intestinal and immunological disease.
Salter CG., Cai Y., Lo B., Helman G., Taylor H., McCartney A., Leslie JS., Accogoli A., Zara F., Traverso M., Fasham J., Lees JA., Ferla M., Chioza BA., Wenger O., Scott E., Cross HE., Crawford J., Warshawsky I., Keisling M., Agamanolis D., Melver CW., Cox H., Elawad M., Marton T., Wakeling M., Holzinger D., Tippelt S., Munteanu M., Valcheva D., Deal C., Van Meerbeke S., Vockley CW., Butte MJ., Acar U., van der Knaap MS., Korenke GC., Kotzaeridou U., Balla T., Simons C., Uhlig HH., Crosby AH., De Camilli P., Wolf NI., Baple EL.
Phosphatidylinositol 4-kinase IIIα (PI4KIIIα/PI4KA/OMIM:600286) is a lipid kinase generating phosphatidylinositol 4-phosphate (PI4P), a membrane phospholipid with critical roles in the physiology of multiple cell types. PI4KIIIα's role in PI4P generation requires its assembly into a heterotetrameric complex with EFR3, TTC7 and FAM126. Sequence alterations in two of these molecular partners, TTC7 (encoded by TTC7A or TCC7B) and FAM126, have been associated with a heterogeneous group of either neurological (FAM126A) or intestinal and immunological (TTC7A) conditions. Here we show that biallelic PI4KA sequence alterations in humans are associated with neurological disease, in particular hypomyelinating leukodystrophy. In addition, affected individuals may present with inflammatory bowel disease, multiple intestinal atresia and combined immunodeficiency. Our cellular, biochemical and structural modelling studies indicate that PI4KA-associated phenotypical outcomes likely stem from impairment of molecular roles requiring organ specific PI4KIIIα-TTC7-FAM126 complex functional interactions. Together these data define PI4KA gene alteration as a cause of a variable phenotypical spectrum and provide fundamental new insight into the combinatorial biology of the PI4KIIIα-FAM126-TTC7-EFR3 molecular complex.